)
)
InMed Pharmaceuticals Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from InMed Pharmaceuticals Inc
Access all reports
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. It uses its drug development programs to treat diseases with high unmet medical need. The company's product pipelines include Epidermolysis Bullosa, Glucocerebrosidase Deficiency, Ocular Scarring, and Transdermal Cannabinoid delivery system. Its platform technology includes Biosynthesis process for natural plant-based cannabinoids, Bioinformatics databases to assess the pharmacological activity of existing and novel cannabinoids, and Drug delivery platforms that provide targeted therapeutic options. The company was formerly known as InMed BioPharma Inc. and changed its name to InMed Pharmaceuticals Inc. in December 2016. InMed Pharmaceuticals Inc. was founded in 2011 and is based in Vancouver, Canada.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
INM
Country
🇺🇸 United States